Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma
Open Access
- 1 October 1999
- Vol. 86 (7) , 1109-1115
- https://doi.org/10.1002/(sici)1097-0142(19991001)86:7<1109::aid-cncr3>3.0.co;2-g
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatinBritish Journal of Cancer, 1993
- A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancerCancer, 1993
- Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: A Phase II trialAnnals of Oncology, 1991
- Platinum and other metal coordination compounds in cancer chemotherapy. A commentary on the sixth international symposium: San Diego, California, 23-26th January 1991British Journal of Cancer, 1991
- Cisplatin/carboplatin cross-resistance in ovarian cancerBritish Journal of Cancer, 1989
- Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.Journal of Clinical Oncology, 1989
- Current status of chemotherapy for gastric cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Cis-platinum as second-line chemotherapy in advanced gastric adenocarcinoma. A phase II study of the EORTC gastrointestinal tract cancer cooperative groupEuropean Journal of Cancer and Clinical Oncology, 1985
- A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric CarcinomaJAMA, 1985
- 5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric CancerAnnals of Internal Medicine, 1980